MedTrace Logo

Marine Protein Hydrolysate as Dietary Supplement in Elderly Part I

NCT03669796 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2019-11-14

No results posted yet for this study

Summary

The aim of this study is to investigate the potential effect of a marine protein hydrolysate (MPH) supplement before a meal on postprandial glucose tolerance in healthy subjects, to achieve more knowledge on this presumed beneficial, blood glucose lowering effect

Conditions

  • Healthy Volunteers

Interventions

DIETARY_SUPPLEMENT

Marine protein hydrolysate (mph)

Marine (Cod) protein hydrolysate

DIETARY_SUPPLEMENT

Control

Maltodextrin/Casein

Sponsors & Collaborators

  • Haukeland University Hospital

    collaborator OTHER

  • Helse Møre og Romsdal HF

    lead OTHER_GOV

Principal Investigators

  • Dag Arne Lihaug Hoff, MD, PhD · Møre & Romsdal Hospital Trust, Ålesund Hospital

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-11-27
Primary Completion
2018-02-28
Completion
2018-02-28

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03669796 on ClinicalTrials.gov